AbGn-201

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAbGn-201

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAltrubio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAltrubio Inc

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A